Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Co (NYSE:LLY) announced that the U.S.
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Co (NYSE:LLY) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
J.P.
This morning Eli Lilly and Co (NYSE:LLY) announced that its Phase 3 EXPEDITION-3 trial evaluating solanezumab in Alzheimer’s failed. LLY noted that while …
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Company (NYSE:LLY) announced that detailed results of RA-BEACON — a pivotal phase 3 global study of baricitinib, a …
Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced a global collaboration and license agreement with Eli Lilly and Co (NYSE:LLY) to develop and commercialize products combining …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
